Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review

BACKGROUND: Asthma affects millions of patients across the globe and also accounts for numerous mortalities every year. The current pharmacologic approach to the treatment of asthma includes the use of glucocorticoids and beta-agonists mainly. However, these conventional therapies have poor controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathinam, Kiran Kumar, Abraham, Justin Jacob, Vijayakumar, Thangavel Mahalingam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911908/
https://www.ncbi.nlm.nih.gov/pubmed/31871508
http://dx.doi.org/10.1016/j.curtheres.2019.100571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911908/
https://www.ncbi.nlm.nih.gov/pubmed/31871508
http://dx.doi.org/10.1016/j.curtheres.2019.100571

Ejemplares similares